#Inzymes
November 16, 2026 at 11:42 PM
Dyadic signs development & commercial license with undisclosed European biotech for precision-fermented proteins.
Builds on other deals for dairy proteins & enzymes with Inzymes & BRIG BIO.
Next steps: strain optimization, process development & commercial scale up.
#$DYAI
dyadic.com/dyadic-expan...
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement - Dyadic
JUPITER, Fla., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) ("Dyadic" or the "Company"), d/b/a Dyadic Applied BioSolutions, a
dyadic.com
August 4, 2026 at 12:41 PM
Dyadic & Inzymes announce anticipated commercialization of non-animal dairy enzyme this year
*cheese & dairy applications
*$.2mm milestone received
#$DYAI
finance.yahoo.com/news/dyadic-...
Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone
JUPITER, Fla. and COPENHAGEN, Denmark, March 02, 2026 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company pro...
finance.yahoo.com
March 2, 2026 at 1:00 PM
Dyadic Applied Biosolutions reports 3Q
*call @ 5 pm ET
*1st purchase order for cell culture media
*Proliant & Inzymes milestones paid
$DYAI
dyadic.com/dyadic-annou...
Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress - Dyadic
JUPITER, Fla., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), d/b/a, Dyadic
dyadic.com
November 12, 2025 at 9:17 PM
Dyadic announces milestones
*Proliant/albumin-$500k for productivity
*Transferrin-initial production & validation underway
*DNase I-met activity & purity benchmarks & production underway
*α-lactalbumin term sheet signed
*Inzymes-$250k for productivity
$DYAI
finance.yahoo.com/news/dyadic-...
Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments
JUPITER, Fla., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc., d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology co...
finance.yahoo.com
October 6, 2025 at 4:05 PM